We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.77%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEO icon
676
American Eagle Outfitters
AEO
$3.01B
$789K 0.03%
+72,414
New +$685K
WTW icon
677
Willis Towers Watson
WTW
$32B
$788K 0.03%
+4,001
New +$766K
IPHI
678
DELISTED
INPHI CORPORATION
IPHI
$788K 0.03%
6,710
+6,125
+1,047% +$645K
KHC icon
679
Kraft Heinz
KHC
$30B
$787K 0.03%
24,701
+24,559
+17,295% +$737K
AGCO icon
680
AGCO
AGCO
$7.2B
$786K 0.03%
14,164
+10,882
+332% +$568K
NBIS
681
Nebius Group N.V.
NBIS
$47.7B
$784K 0.03%
15,683
+13,794
+730% +$552K
PRLB icon
682
Protolabs
PRLB
$2.13B
$783K 0.03%
6,960
+6,927
+20,991% +$711K
ROP icon
683
Roper Technologies
ROP
$39.8B
$779K 0.03%
+2,007
New +$719K
XEL icon
684
Xcel Energy
XEL
$48.8B
$778K 0.03%
12,452
+9,772
+365% +$616K
BBIO icon
685
BridgeBio Pharma
BBIO
$16.5B
$775K 0.03%
+23,776
New +$724K
LPX icon
686
Louisiana-Pacific
LPX
$5.49B
$775K 0.03%
+30,207
New +$639K
NVT icon
687
nVent Electric
NVT
$26.7B
$775K 0.03%
+41,359
New +$753K
RDS.B
688
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$775K 0.03%
25,447
+22,252
+696% +$727K
KLAC icon
689
KLA
KLAC
$259B
$774K 0.03%
39,780
-76,630
-66% -$1.31M
ALXN
690
DELISTED
Alexion Pharmaceuticals
ALXN
$772K 0.03%
6,871
+5,992
+682% +$636K
BP icon
691
BP
BP
$107B
$770K 0.03%
33,027
+24,283
+278% +$583K
EXC icon
692
Exelon
EXC
$47B
$770K 0.03%
29,732
+19,430
+189% +$516K
FXR icon
693
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$766M
$770K 0.03%
20,340
-15,845
-44% -$552K
MTZ icon
694
MasTec
MTZ
$21.9B
$770K 0.03%
17,161
+17,114
+36,413% +$649K
RSPH icon
695
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$784M
$768K 0.03%
34,550
-28,340
-45% -$607K
JBLU icon
696
JetBlue
JBLU
$2.29B
$767K 0.03%
70,371
+35,464
+102% +$349K
SLT
697
DELISTED
Pacer Salt High truBeta US Market ETF
SLT
$765K 0.03%
29,675
+9,439
+47% +$219K
NVRO
698
DELISTED
NEVRO CORP.
NVRO
$762K 0.03%
6,378
+6,294
+7,493% +$747K
OKE icon
699
Oneok
OKE
$54.5B
$760K 0.03%
22,849
-18,682
-45% -$609K
TNDM icon
700
Tandem Diabetes Care
TNDM
$1.56B
$760K 0.03%
+7,676
New +$613K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.